Delivery Order SPE2DB20D3103-SPE2DB25FP6K4
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,138.54 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that provides comprehensive pharmaceutical and...
- The Defense Logistics Agency awarded a delivery order valued at $54,355.68 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets in quantities of 30 units, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and...
- The Defense Logistics Agency awarded a delivery order valued at $4,724.63 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a delivery order valued at $8,396.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,406.11 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packages). This competitive award, made on September 16, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $60.3K to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (UU 28S) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a JAK inhibitor used to treat rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $6,912.27 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of RINVOQ ER 15 MG tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,803.83 for RINVOQ ER 15 mg tablets (30-count units) on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $12.3K to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a $26,502.96 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This competitive award, utilizing firm fixed pricing, represents a non-set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. RINVOQ ER is a prescription medication used to treat inflammatory conditions, and this delivery order fulfills a specific pharmaceutical...